Back to Search
Start Over
Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro.
- Source :
-
British journal of pharmacology [Br J Pharmacol] 2007 Sep; Vol. 152 (2), pp. 223-9. Date of Electronic Publication: 2007 Jul 09. - Publication Year :
- 2007
-
Abstract
- Background and Purpose: Raloxifene improves cardiovascular function. This study examines the hypothesis that therapeutic concentrations of raloxifene augment endothelium-dependent relaxation via up-regulation of eNOS expression and activity in porcine coronary arteries.<br />Experimental Approach: Isometric tension was measured in rings from isolated arteries. Intracellular Ca(2+) concentrations ([Ca(2+)](i)) in arterial endothelial cells were detected by Ca(2+) fluorescence imaging. Phosphorylation of eNOS at Ser-1177 was assayed by Western blot analysis.<br />Key Results: In arterial rings pre-contracted with 9,11-dideoxy-11alpha,9alpha-epoxy-methano-prostaglandin F(2alpha) (U46619), treatment with raloxifene (1-3 nM) augmented bradykinin- or substance P-induced relaxation and this effect was antagonized by ICI 182,780, an estrogen receptor antagonist. The enhanced relaxation was abolished in rings treated with inhibitors of nitric oxide/cyclic GMP-dependent dilation, N(G)-nitro-L-arginine methyl ester (L-NAME) plus 1H-[1,2,4]oxadizolo[4,3-a]quinoxalin-1-one (ODQ). In contrast, effects of raloxifene were unaffected after inhibition of endothelium-derived hyperpolarizing factors by charybdotoxin plus apamin. Raloxifene (3 nM) did not influence endothelium-independent relaxation to sodium nitroprusside. 17beta-Estradiol (3-10 nM) also enhanced bradykinin-induced relaxation, which was inhibited by ICI 182,780. Treatment with raloxifene (3 nM) did not affect bradykinin-stimulated rise in endothelial cell [Ca(2+)](i). Raloxifene, 17beta-estradiol, and bradykinin increased eNOS phosphorylation at Ser-1177 and ICI 182,780 prevented effects of raloxifene or 17beta-estradiol but not that of bradykinin. Raloxifene had neither additive nor antagonistic effects on 17beta-estradiol-induced eNOS phosphorylation.<br />Conclusions and Implications: Raloxifene in therapeutically relevant concentrations augmented endothelial function in porcine coronary arteries in vitro through ICI 182,780-sensitive mechanisms that were associated with increased phosphorylation of eNOS but independent of changes in endothelial cell [Ca(2+)](i).
- Subjects :
- Animals
Bradykinin pharmacology
Coronary Vessels physiology
Estradiol analogs & derivatives
Estradiol pharmacology
Estrogen Antagonists pharmacology
Fulvestrant
In Vitro Techniques
Muscle, Smooth, Vascular drug effects
Muscle, Smooth, Vascular physiology
Nitric Oxide Synthase Type III metabolism
Swine
Vasodilation drug effects
Coronary Vessels drug effects
Nitric Oxide metabolism
Raloxifene Hydrochloride pharmacology
Vasodilator Agents pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0007-1188
- Volume :
- 152
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- British journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 17618301
- Full Text :
- https://doi.org/10.1038/sj.bjp.0707387